Edition:
United Kingdom

Profile: Sun Pharma Advanced Research Company Ltd (SPRC.NS)

SPRC.NS on National Stock Exchange of India

146.55INR
11:11am BST
Change (% chg)

Rs3.20 (+2.23%)
Prev Close
Rs143.35
Open
Rs143.70
Day's High
Rs147.70
Day's Low
Rs142.75
Volume
285,665
Avg. Vol
985,290
52-wk High
Rs438.00
52-wk Low
Rs130.00

Sun Pharma Advanced Research Company Limited is engaged in the research and experimental development on natural sciences and engineering (Pharmacy). The Company operates through Pharmaceuticals Research & Development segment. Its programs include Xelpros, Elepsia XR, Baclofen GRS, Paclitaxel Injection Concentrate for Nanodispersion (Taclantis), Salmeterol - Fluticasone Dry Powder Inhaler (DPI), SUN-K706, Brimonidine OD, Tizanidine ER, Minocycline Topical and SUN-597 Topical. Xelpros is a Benzalkonium Chloride (BAK)-free Latanoprost eye drops developed with its Swollen Micelle Microemulsion (SMM) technology. Elepsia XR is a once-a-day formulation of Levetiracetam, an antiepileptic agent. Baclofen GRS is a once-a-day formulation of Baclofen, a centrally acting, antispasmodic drug. Taclantis is a Cremophor and Albumin free formulation. Its DPI is a premetered, 60 doses, breath activated device to administer combination of Salmeterol and Fluticasone by inhalation.

Company Address

Sun Pharma Advanced Research Company Ltd

17B Mahal Industrial Estate
Mahakali Caves Road, Andheri (Ea
MUMBAI     400093
P: +9122.66455685
F: +9122.66455685

Company Web Links